Question 1

What is the catalog number for BDA366?

Accepted Answer

The catalog number for BDA366 is B1827-25.

Question 2

Is BDA366 in stock?

Accepted Answer

BDA366 is currently made to order / not held in immediate stock. Contact us for lead time.

Question 3

What is BDA366 used for?

Accepted Answer

BDA-366 is a small-molecule Bcl2-BH4 domain antagonist, that binds BH4 with high affinity and selectivity. BDA-366-Bcl2 binding induces conformational change in Bcl2 that abrogates its antiapoptotic function, converting it from a survival molecule to a cell death inducer.

Question 4

Can I request additional validation data, such as western blot images, for this product?

Accepted Answer

Additional data may be available on request. Contact our technical support team with the catalogue number and we’ll check what supporting documentation the supplier can provide.

Question 5

What documentation should I request if this product is used for a regulated or intellectual-property-sensitive application?

Accepted Answer

If the product is subject to intellectual property protections, we’ll advise on any MTA or usage restrictions before shipping. Let us know your intended end use so we can confirm what’s required upfront.

Question 6

Is this antibody conjugated?

Accepted Answer

Conjugation status, such as unconjugated, HRP, FITC, or biotin, is specified in the product name and confirmed on the datasheet.

BDA366

Product Specifications

Shipping Conditions

Storage Conditions

Shelf Life

Frequently Asked Questions

Explore Other Products

NR0B2 Antibody, FITC conjugated

NR0B2 Antibody, FITC conjugated

NR0B2 Antibody, FITC conjugated

Tylosin A EvoPure®

Vaccinia Virus (NYCBH, Lister strain) (MaxLight 650) discontinued

Lentiviral mouse Plekho2 shRNA (UAS) - Lentiviral mouse Plekho2 shRNA (UAS) (25)